Lux Health Tech Acquisition Corp. Announces Cancellation of Special Meeting of Stockholders and Liquidation
07 Outubro 2022 - 5:15PM
Business Wire
Lux Health Tech Acquisition Corp. (the “Company”) today
announced that it has cancelled its special meeting of stockholders
that was previously scheduled for 9:00 AM Pacific time on October
13, 2022, and that, because the Company will not consummate an
initial business combination within the time period required by its
Second Amended and Restated Certificate of Incorporation, the
Company intends to dissolve and liquidate, effective as of the
close of business on October 29, 2022, and will redeem all of the
outstanding shares of Class A common stock that were included in
the units issued in its initial public offering (the “Public
Shares”), at a per-share redemption price of approximately
$10.04.
As of the close of business on October 29, 2022, the Public
Shares will be deemed cancelled and will represent only the right
to receive the redemption amount. Record holders will receive their
pro rata portion of the proceeds of the trust account by delivering
their Public Shares to Continental Stock Transfer & Trust
Company, the Company’s transfer agent. Beneficial owners of Public
Shares held in “street name,” however, will not need to take any
action in order to receive the redemption amount. The redemption of
the Public Shares is expected to be completed within ten business
days after October 29, 2022.
The Company’s sponsor has agreed to waive its redemption rights
with respect to its outstanding Class B common stock issued prior
to the Company’s initial public offering. There will be no
redemption rights or liquidating distributions with respect to the
Company’s warrants, which will expire worthless.
The Company expects that Nasdaq will file a Form 25 with the
United States Securities and Exchange Commission (the “Commission”)
to delist the Company’s securities. The Company thereafter expects
to file a Form 15 with the Commission to terminate the registration
of its securities under the Securities Exchange Act of 1934, as
amended.
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking
statements are based on the Company’s current expectations and are
subject to numerous conditions, risks and uncertainties, which
could cause actual results to differ materially from those
reflected in the statements, many of which are beyond the control
of the Company, including those set forth in the Risk Factors
section of the Company’s Annual Report on Form 10-K for the year
ended December 31, 2021, filed with the SEC on March 30, 2022, and
the Company’s quarterly reports on Form 10-Q filed with the SEC,
each available on the SEC’s website, www.sec.gov. Investors are
cautioned that any forward-looking statements are not guarantees of
future performance and actual results or developments may differ
materially from the projections in the forward-looking statements.
The Company undertakes no obligation to update these statements for
revisions or changes after the date of this release, except as
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221007005113/en/
Investor Contact: Scott Rubin Email:
scott.rubin@luxcapital.com
Lux Health Tech Acquisit... (NASDAQ:LUXA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Lux Health Tech Acquisit... (NASDAQ:LUXA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024